25 /100
LOW RISK
Score updated Jul 13, 2026

SABR — Sabre Corporation Dilution Risk Tracker

Track SABR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SABR — Get alerts when the score changes →

As of July 13, 2026, Sabre Corporation (SABR) has a DilutionWatch DilutionScore of 25/100, rated LOW dilution risk. Sabre Corporation has a market capitalization of $695.75M, 395.31M shares outstanding, 250 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
22
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.67 approaching $1 threshold
🔔 Track SABR — Get forecast alerts →

💹 Market Data

Market Cap$695.75M
Shares Outstanding395.31M
Float262.21M
Cash$643.58M
Debt$4.27B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 4.0% shares (2026Q1 vs prior)
250 institutional holders · 394.45M shares
#1 BlackRock, Inc. 57.47M shares
#2 Discerene Group LP 39.09M shares
#3 Arini Captial Management Ltd 36.61M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest35.68M
Days to Cover5.4
% of Float13.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2023
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for SABR Shareholders

Sabre Corporation (SABR) has a DilutionScore of 25/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for SABR shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for SABR in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for SABR alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track SABR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SABR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for SABR
📊 SABR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SABR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.